Cleared Special

Prestige Coil System (K220699) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K220699 · Bait USA, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2022
Decision
29d
Days
Class 2
Risk

K220699 is an FDA 510(k) clearance for the Prestige Coil System. Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Bait USA, LLC (Irvine, US). The FDA issued a Cleared decision on April 8, 2022 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bait USA, LLC devices

Submission Details

510(k) Number K220699 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2022
Decision Date April 08, 2022
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 70
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K220699.
GEM
K213385 · Obsidio, Inc. · Jul 2022
LOBO Vascular Occlusion System (models LOBO-7 and LOBO-9)
K220383 · Okami Medical · Apr 2022
EMBOLD Fibered Detachable Coil System
K213398 · Boston Scientific Corporation · Apr 2022
Solus Gold Embolization Device
K213200 · Artio Medical, Inc. · Mar 2022
Endoluminal Occlusion System, EOS-X, Endoluminal Occlusion System, EOS
K212057 · Artventive Medical Group, Inc. · Mar 2022
Merit Siege Vascular Plug
K212817 · Merit Medical System, Inc. · Dec 2021